
TheEpochTimes.com
Rick Alderson was a retired sawmill worker who was diagnosed with terminal colon cancer in November 2020.
He experienced excruciating pain in his bowels for months; then, a gastroenterologist found a large tumor in his rectum and told him and his wife he only had six months to live.
To the oncologist, Mr. Alderson “was a dead man walking,” Mr. Alderson’s wife, Eve Alderson, told The Epoch Times.
Doctors were against starting him on treatment due to Mr. Alderson’s age and the severity of his cancer, but Mr. and Mrs. Alderson determined that their fate was in God’s hands and decided to do whatever they could.
Mr. Alderson got started with 10 rounds of radiation therapy. Initially, his carcinoembryonic antigen (CEA), a marker for tumor activity, was significantly elevated at 480 nanograms per milliliter (ng/mL). A month later, he started chemotherapy. By then, his CEA levels had risen to 1,498 ng/mL.
By the time Mr. Alderson started treatment, his colon cancer had metastasized and spread to his liver, where he had 25 tumors.
“I was off their charts,” Mr. Alderson said in an interview with The Cancer Box, a cancer diagnosis blog.
Due to concerns about COVID-19 and the ongoing pandemic, Mr. Alderson started looking into preventative medication and found ivermectin.
Further research showed that the drug could likely enhance the effectiveness of his chemotherapy and radiation therapy and was relatively safe. In February 2021, he began taking ivermectin.
Ten days later, his CEA levels had dropped to 184 ng/mL.
Come March, the number was 47.9 ng/mL. By April 7, it was 20.7; by April 21, it had dropped to 13.9 ng/mL. By midsummer, it had fallen into the normal range. Of the 25 tumors in his liver, only three remained.